Oncology Nursing News®
Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.
Oncology Nursing News CE
Current Issue
August 2018
View Past Issues
OncNurse TV
Choosing an Iron Chelation Therapy for a Patient with MDS
Choosing an Iron Chelation Therapy for a Patient with MDS
Balancing AEs With Improved Survival in Myeloma
Balancing AEs With Improved Survival in Myeloma
Cancer Care Takes a Team
Cancer Care Takes a Team
View more >>

Oncology Nursing Articles

FDA Grants Full Approval to Combination Use of Pembrolizumab, Chemotherapy for NSCLC
FDA Grants Full Approval to Combination Use of Pembrolizumab, Chemotherapy for NSCLC
BY JASON M. BRODERICK
CALM Intervention May Reduce Distress in Patients With Advanced Cancer
CALM Intervention May Reduce Distress in Patients With Advanced Cancer
BY LISA SCHULMEISTER, MN, RN, FAAN
Tumor Treating Fields May Address Unmet Need in Ovarian Cancer Treatment
Tumor Treating Fields May Address Unmet Need in Ovarian Cancer Treatment
BY AUDREY STERNBERG
FDA Approves Nivolumab for Small Cell Lung Cancer
FDA Approves Nivolumab for Small Cell Lung Cancer
BY JASON M. BRODERICK
Potential Post-Immunotherapy Option Emerges in Urothelial Cancer Treatment
Potential Post-Immunotherapy Option Emerges in Urothelial Cancer Treatment
BY JASON HARRIS
FDA Approves Frontline Lenvatinib for Unresectable HCC
FDA Approves Frontline Lenvatinib for Unresectable HCC
BY JASON M. BRODERICK
Less than Half of Pediatric CNS Cancer Survivors Become Fully Independent Adults
Less than Half of Pediatric CNS Cancer Survivors Become Fully Independent Adults
BY JASON HARRIS
HR+ Breast Cancer Treatments Evolving Rapidly
HR+ Breast Cancer Treatments Evolving Rapidly
BY CAROLINE SEYMOUR
FDA Grants SL-401 Priority Review for Rare Hematologic Cancer
FDA Grants SL-401 Priority Review for Rare Hematologic Cancer
BY
Women May Choose Palliative Care More Often than Men
Women May Choose Palliative Care More Often than Men
BY LISA SCHULMEISTER, MN, RN, FAAN
Managing Adverse Events in Patients Taking Abemaciclib
Managing Adverse Events in Patients Taking Abemaciclib
BY AUDREY STERNBERG
How to Identify and Respond to Immunotherapy-Related Adverse Events
How to Identify and Respond to Immunotherapy-Related Adverse Events
BY AUDREY STERNBERG
View more >>
Latest Contributor Articles
Strategic Alliance Partnership
We've partnered with leading institutions to bring you the most recent findings in the field of oncology. Click below for offerings from our partners
 
Latest Advocacy News
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.